BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6102074)

  • 1. Thrombin-dependent spleen transamidase.
    Zuch A
    Haemostasis; 1980; 9(2):85-91. PubMed ID: 6102074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desmofibrin formation and the activity of the fibrin stabilizing factor (FSF) during the cleavage of its SH groups by thrombin.
    Buluk K; Olbromski J; Januszko T; Zuch A
    Thromb Diath Haemorrh; 1966 Jul; 16(1):51-60. PubMed ID: 5989050
    [No Abstract]   [Full Text] [Related]  

  • 3. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF).
    Ly B; Kierulf P; Jakobsen E
    Thromb Res; 1974 Apr; 4(4):509-22. PubMed ID: 4429641
    [No Abstract]   [Full Text] [Related]  

  • 4. Human epidermal transamidase.
    Goldsmith LA; Martin CM
    J Invest Dermatol; 1975 May; 64(5):316-21. PubMed ID: 237963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships of the catalytic properties of human plasma and platelet transglutaminases (activated blood coagulation factor XIII) to their subunit structures.
    Chung SI; Lewis MS; Folk JE
    J Biol Chem; 1974 Feb; 249(3):940-50. PubMed ID: 4149557
    [No Abstract]   [Full Text] [Related]  

  • 6. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the platelet-dependent fibrin retraction by the fibrin stabilizing factor (FSF, factor 13).
    Niewiarowski S; Markiewicz M; Nath N
    J Lab Clin Med; 1973 May; 81(5):641-50. PubMed ID: 4698655
    [No Abstract]   [Full Text] [Related]  

  • 8. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of soluble, FSF-stabilized fibrin complexes with special reference to the role of fibrinogen.
    Ly B; Kierulf P; Jakobsen E; Gravem K
    Thromb Res; 1974 Jul; 5(1):21-32. PubMed ID: 4428469
    [No Abstract]   [Full Text] [Related]  

  • 10. Significance of the thiol groups in the formation of desmofibrin.
    Buluk K; Zuch A
    Pol Med J; 1971; 10(4):886-94. PubMed ID: 5126382
    [No Abstract]   [Full Text] [Related]  

  • 11. Clottability and cross-linking reactivity of fibrin(ogen) following differential release of fibrinopeptides A and B.
    Furlan M; Seelich T; Beck EA
    Thromb Haemost; 1976 Dec; 36(3):582-92. PubMed ID: 14415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbances of desmofibrinogenesis in pateints suffering from acute myeloblastic leukemia.
    Kłoczko J; Zuch A; Bielawiec M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1980; 107(1):125-30. PubMed ID: 6157614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor.
    Curtis CG; Brown KL; Credo RB; Domanik RA; Gray A; Stenberg P; Lorand L
    Biochemistry; 1974 Aug; 13(18):3774-80. PubMed ID: 4859234
    [No Abstract]   [Full Text] [Related]  

  • 14. Fibrin membrane endowed with biological function. IV. Formation of cross-links between fibrinogen (or fibrin) and ribonuclease by transglutaminase.
    Okamoto H; Kanai S; Tipayang P; Inada Y
    Enzyme; 1979; 24(4):273-6. PubMed ID: 39750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The possibility of proteolytic activation of the fibrin-stabilizing factor.
    Buluk K; Zuch A
    Biochim Biophys Acta; 1967 Dec; 147(3):593-4. PubMed ID: 5625411
    [No Abstract]   [Full Text] [Related]  

  • 16. A peptide released from plasma fibrin stabilzing factor in the conversion to the active enzyme by thrombin.
    Mikuni Y; Iwanaga S; Konishi K
    Biochem Biophys Res Commun; 1973 Oct; 54(4):1393-403. PubMed ID: 4754717
    [No Abstract]   [Full Text] [Related]  

  • 17. Transamidating enzymes in maternal plasma and placenta in human pregnancies complicated by intrauterine growth retardation.
    Persson BL; Stenberg P; Holmberg L; Astedt B
    J Dev Physiol; 1980; 2(1-2):37-46. PubMed ID: 6108341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-linking of fibrinogen and fibrin by fibrin-stablizing factor (factor XIIIa).
    Kanaide H; Shainoff JR
    J Lab Clin Med; 1975 Apr; 85(4):574-97. PubMed ID: 1168234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transamidase kinetics. Amide formation in the enzymic reactions of thiol esters with amines.
    Stenberg P; Curtis CG; Wing D; Tong YS; Credo RB; Gray A; Lorand L
    Biochem J; 1975 Apr; 147(1):155-63. PubMed ID: 239698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.